• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CODX

CODX

Co-Diagnostics, Inc.

NASDAQHealthcareMedical - DevicesUS

USD5.10

-0.07 (-1.37%)

Rating:B-

Company Profile

CEO

Dwight H. Egan

IPO Date

2017-07-12

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.82

Prev. Close

$5.17

Day Low

$4.47

Day High

$5.10

52W Low

$1.26

52W High

$46.50

Market Cap

$0.01B

Volume

0.15M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

42.8%

Avg Negative

3.6%

Avg Neutral

53.6%

News Feed

Why Co-Diagnostics Is A Solid Covid-19 Play

Seeking Alpha·8/19/2021·↑ positive

CoDiagnostics, Inc. (CODX) Just Reclaimed the 20-Day Moving Average

Zacks Investment Research·8/16/2021·↑ positive

Why Co-Diagnostics Zoomed Almost 10% Higher Today

The Motley Fool·8/13/2021·↑ positive

Co-Diagnostics Stock Moves Higher As Q2 Earnings Top Estimates

Benzinga·8/13/2021·↑ positive

Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/12/2021·↓ negative

CoDiagnostics, Inc. (CODX) Surpasses Q2 Earnings and Revenue Estimates

Zacks Investment Research·8/12/2021·↑ positive

Co-Diagnostics sees 2Q revenue rise by 13.8% driven by sales of the Logix Smart COVID-19 Test

Proactive Investors·8/12/2021·↑ positive

Analysts Estimate CoDiagnostics, Inc. (CODX) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research·8/5/2021·↑ positive

Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast

PRNewsWire·8/4/2021·↑ positive

Why Co-Diagnostics Blasted 21% Higher on Thursday

The Motley Fool·7/22/2021·↑ positive